UniProt ID | SH21A_HUMAN | |
---|---|---|
UniProt AC | O60880 | |
Protein Name | SH2 domain-containing protein 1A | |
Gene Name | SH2D1A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 128 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Cytoplasmic adapter regulating receptors of the signaling lymphocytic activation molecule (SLAM) family such as SLAMF1, CD244, LY9, CD84, SLAMF6 and SLAMF7. In SLAM signaling seems to cooperate with SH2D1B/EAT-2. Initially it has been proposed that association with SLAMF1 prevents SLAMF1 binding to inhibitory effectors including INPP5D/SHIP1 and PTPN11/SHP-2. [PubMed: 11806999 However, by simultaneous interactions, recruits FYN which subsequently phosphorylates and activates SLAMF1] | |
Protein Sequence | MDAVAVYHGKISRETGEKLLLATGLDGSYLLRDSESVPGVYCLCVLYHGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKNLISAFQKPDQGIVIPLQYPVEKKSSARSTQGTTGIREDPDVCLKAP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MDAVAVYHGKISRE -CCEEEEECCEECHH | 8.63 | 24719451 | |
10 | Ubiquitination | AVAVYHGKISRETGE EEEEECCEECHHHCC | 24.97 | 24816145 | |
12 | Phosphorylation | AVYHGKISRETGEKL EEECCEECHHHCCEE | 27.78 | 24719451 | |
15 | Phosphorylation | HGKISRETGEKLLLA CCEECHHHCCEEEEE | 49.91 | 23879269 | |
18 | Ubiquitination | ISRETGEKLLLATGL ECHHHCCEEEEEECC | 45.86 | - | |
23 | Phosphorylation | GEKLLLATGLDGSYL CCEEEEEECCCCCEE | 37.94 | 24719451 | |
28 | Phosphorylation | LATGLDGSYLLRDSE EEECCCCCEECCCCC | 16.57 | 24719451 | |
29 | Phosphorylation | ATGLDGSYLLRDSES EECCCCCEECCCCCC | 18.45 | 24719451 | |
74 | Ubiquitination | ETAPGVHKRYFRKIK CCCCCHHHHHHHHHH | 46.52 | - | |
81 | Ubiquitination | KRYFRKIKNLISAFQ HHHHHHHHHHHHHHC | 49.05 | 29967540 | |
89 | Acetylation | NLISAFQKPDQGIVI HHHHHHCCCCCCEEE | 44.07 | 19608861 | |
89 | Ubiquitination | NLISAFQKPDQGIVI HHHHHHCCCCCCEEE | 44.07 | 19608861 | |
104 | Ubiquitination | PLQYPVEKKSSARST EECCEECCCCCCCCC | 59.18 | - | |
105 | Ubiquitination | LQYPVEKKSSARSTQ ECCEECCCCCCCCCC | 35.82 | - | |
106 | Phosphorylation | QYPVEKKSSARSTQG CCEECCCCCCCCCCC | 40.05 | 22817900 | |
107 | Phosphorylation | YPVEKKSSARSTQGT CEECCCCCCCCCCCC | 36.26 | 22817900 | |
110 | Phosphorylation | EKKSSARSTQGTTGI CCCCCCCCCCCCCCC | 25.46 | 27251275 | |
111 | Phosphorylation | KKSSARSTQGTTGIR CCCCCCCCCCCCCCC | 26.01 | - | |
114 | Phosphorylation | SARSTQGTTGIREDP CCCCCCCCCCCCCCC | 16.42 | - | |
115 | Phosphorylation | ARSTQGTTGIREDPD CCCCCCCCCCCCCCC | 37.12 | - | |
126 | Ubiquitination | EDPDVCLKAP----- CCCCCCEECC----- | 54.18 | 24816145 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SH21A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SH21A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SH21A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SLAF1_HUMAN | SLAMF1 | physical | 11806999 | |
SLAF5_HUMAN | CD84 | physical | 12928397 | |
FYN_HUMAN | FYN | physical | 12458214 | |
SLAF5_HUMAN | CD84 | physical | 11389028 | |
LY9_HUMAN | LY9 | physical | 11389028 | |
DOK1_HUMAN | DOK1 | physical | 10852966 | |
SLAF1_HUMAN | SLAMF1 | physical | 11477068 | |
CD244_HUMAN | CD244 | physical | 11477068 | |
LY9_HUMAN | LY9 | physical | 11477068 | |
SLAF5_HUMAN | CD84 | physical | 11477068 | |
EGFR_HUMAN | EGFR | physical | 16273093 | |
ERBB3_HUMAN | ERBB3 | physical | 16273093 | |
ACK1_HUMAN | TNK2 | physical | 25416956 | |
LHX4_HUMAN | LHX4 | physical | 25416956 | |
FAK1_HUMAN | PTK2 | physical | 25814554 | |
ZNHI1_HUMAN | ZNHIT1 | physical | 25814554 | |
ATF3_HUMAN | ATF3 | physical | 25814554 | |
CC74A_HUMAN | CCDC74A | physical | 25814554 | |
LTMD1_HUMAN | LETMD1 | physical | 25814554 | |
NGEF_HUMAN | NGEF | physical | 25814554 | |
OLIG1_HUMAN | OLIG1 | physical | 25814554 | |
TERA_HUMAN | VCP | physical | 19570996 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
308240 | Lymphoproliferative syndrome, X-linked, 1 (XLP1) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-89, AND MASS SPECTROMETRY. |